Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002526485 | SCV000561273 | likely benign | Rienhoff syndrome | 2024-12-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001584190 | SCV001811607 | likely benign | not provided | 2020-08-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341110 | SCV002641005 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-02-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV002341110 | SCV003837800 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-01-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003488626 | SCV004242111 | benign | not specified | 2023-12-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003970345 | SCV004779152 | likely benign | TGFB3-related disorder | 2019-08-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |